Market Tracker

07/29 6:45pm ET

TESARO Inc (NASDAQ:TSRO)

93.24
Delayed Data
As of Jul 29
 -0.38 / -0.41%
Today’s Change
29.51
Today|||52-Week Range
94.48
+78.21%
Year-to-Date
Here's Why Myriad Genetics Is Down 26% in 2016
Jul 21 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close93.62
Today’s open93.00
Day’s range91.18 - 93.83
Volume1,357,118
Average volume (3 months)1,009,660
Market cap$4.6B
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-33.19%
Earnings growth (this year)-11.19%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales6,500.72
Price/Book43.30

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA+0.30+1.80%
ACADACADIA Pharmaceutica...+0.30+0.82%
UTHRUnited Therapeutics ...+2.02+1.70%
ICPTIntercept Pharmaceut...+6.13+3.67%
Data as of 3:59pm ET, 07/29/2016

Financials

Next reporting dateAugust 5, 2016
EPS forecast (this quarter)-$1.70
Annual revenue (last year)$317.0K
Annual profit (last year)-$251.4M
Net profit margin-79,308.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Leon O. Moulder
President, Chief Operating Officer &
Director
Mary Lynne Hedley
Corporate headquarters
Waltham, Massachusetts

Forecasts